Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,571,214 papers from all fields of science
Search
Sign In
Create Free Account
Enoxacin:Susc:Pt:Isolate:OrdQn:MIC
Known as:
Enoxacin Islt MIC
, Enoxacine:Gevoeligheid:Moment:Isolaat:OrdinaalKwantitatief:Mininmaal inhiberende concentratie
, Enoxacina:Susc:Pt:Isolato:OrdQn:MIC
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Enoxacin
Isolate - microorganism
Minimum Inhibitory Concentration measurement
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Pharmacokinetics of ciprofloxacin
T. Bergan
,
A. Dalhoff
,
R. Rohwedder
Infection
2005
Corpus ID: 24692220
SummaryThe fluorination of piperazinyl substituted quinolones has led to an interesting development of a series of new broad…
Expand
2005
2005
The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin
R. Wise
,
D. Lister
,
C. Mcnulty
,
D. Griggs
,
J. Andrews
Infection
2005
Corpus ID: 21959049
SummaryThe pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norfloxacin (400 mg p.o…
Expand
2005
2005
In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections
K. Naber
,
B. Bartosik-Wich
,
F. Sörgel
,
F. Gutzler
Infection
2005
Corpus ID: 23558898
SummaryMinimal inhibitory concentrations (MIC) of enoxacin, nalidixic acid, pipemidic acid, norfloxacin, ciprofloxacin, ofloxacin…
Expand
2005
2005
In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections
K. Naber
,
B. Bartosik-Wich
,
F. Sörgel
,
F. Gutzler
Infection
2005
Corpus ID: 23938877
SummaryMinimal inhibitory concentrations (MIC) of enoxacin, nalidixic acid, pipemidic acid, norfloxacin, ciprofloxacin, ofloxacin…
Expand
2005
2005
Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections
P. Federspil
,
A. Lind
,
B. Schmidt
,
E. Tiesler
Infection
2005
Corpus ID: 26964943
SummaryThe efficacy and tolerance of enoxacin were tested in 65 patients treated for ear, nose and throat infections with doses…
Expand
2005
2005
Enoxacin-Konzentrationen im Serum und in der Dickdarmwand während eines kolorektalen Eingriffs
M. Wenzel
,
F. Sörgel
,
P. Muth
,
H. Kraeft
Infection
2005
Corpus ID: 46976255
ZusammenfassungEin zur Infektionsprophylaxe in der Dickdarmchirurgie verwendetes Antibiotikum muß während der Operation…
Expand
2005
2005
Enoxacin und Theophyllin
Firma Parke-Davis
,
Enoxacin und Theophyllin
Infection
2005
Corpus ID: 46966655
Bei zwei Studien an Patienten mit chronischen obstruktiven Lungenerkrankungen (1, 2) zeigte sich, dab bei gleichzeitiger…
Expand
2005
2005
Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole
W. Heizmann
,
R. Schmid
,
F. Heilmann
,
H. Werner
Infection
2005
Corpus ID: 24926809
SummaryIn infections of polymicrobial etiology, it seems mandatory to combine an antibiotic with marginal activity against…
Expand
2005
2005
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice
N. Klesel
,
M. Limbert
,
G. Seibert
,
I. Winkler
,
E. Schrinner
Infection
2005
Corpus ID: 23516428
SummaryThe chemotherapeutic activity of ofloxacin (HOE 280), a new pyridone-carboxylic acid derivative, was compared with that of…
Expand
2005
2005
Empfindlichkeit klinisch wichtiger Bacteroides spp. gegenüber den Kombinationen Enoxacin-Metronidazol und Enoxacin-Clindamycin
W. Heizmann
,
H. Werner
,
R. Schmid
Infection
2005
Corpus ID: 46967286
ZusammenfassungDie minimalen Hemmkonzentrationen (MHK) von Enoxacin, Clindamycin und Metronidazol wurden bei klinischen Isolaten…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE